IGA IGA
Company Profile ↓Company Overview
IGA (IGA) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Growth & Price Performance
Stock Price Performance
| 1 Year: | +18.38% |
| 6 Months: | +13.90% |
| 3 Months: | +12.22% |
| 1 Month: | +4.16% |
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)64.42 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for IGA
Voya Global Advantage and Premium Opportunity Fund (IGA) Chart and Price History 2026 - marketbeat.com
<a href="https://news.google.com/rss/articles/CBMiXkFVX3lxTE56b1ltRnBKUHJrOVFHbGQtQ043aFpxVk56S0xnZ3FTd0x6VHRwbXQwdUdBWkZuVW95THJOYXpoVzZRRVlXaXlMQXRvajZuZnN3RHdqYWZRNWZjZXh6MVE?oc=5" target="_blank">Voya Global Advantage and Premium Opport…
Voya Global Advantage and Premium Opportunity Fund (IGA) 10K Form and Latest SEC Filings 2026 - marketbeat.com
<a href="https://news.google.com/rss/articles/CBMiZkFVX3lxTE0zWkJqSXE4cVNUazdEUUEtdjRXd2IyRjhybVQ3RGNSbkhacm16T1JIYTNXMHF3V2pkQUNyR0hkRDZDRUFUb0w4b2dlbnJ2V2VuUkhMMmxvYzdsbGQ2MVBkSmo4dGhsQQ?oc=5" target="_blank">Voya Global Advantage and Pre…
Voya Global Advantage And Premium Opportunity Fund Q2 2026 Commentary - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxPdWp1N0xfRHJ0eGF0em5XaFhxeU1rSG9Qd3JyS2VvTzJyajdPREhvVUhNNnhOTGtyT0xMR0J1c2VqRUJHcjBkWmlpX0N6OUtMWFEtWHRWV1NtMjAzaGt5cHRTUGtLWVZ6djlaRlBiaFU2SHdwdmN1RzU2bmtMdHhVSWVGWDRmSTJ0dnZrdU…
Should Climb Bio’s IgA Nephropathy Phase 2 Partnership Shift How CLYM Investors View Its Pipeline Strategy? - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi2gFBVV95cUxPRnhPTjJfcjJzUkZLVGNUeVpzdERCQWhDX0ExajhPRWN1WWdVazllNmJBcDgtYi1WOHpSdnlyRW9naXkzWFVFVW9Cc0JqaS1nM0NXOUowZy04ak5CbzhPVjlXMmNjcW5IQk80RnRjbFpFUlVOQVhZWUgzSUhkTW1HY0RuWDdPb09kcXhQcT…
IGA Struggles to Stock Shelves Due to Difficulties with Wholesalers - The Oberlin Review
<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTE9TajYzWkNFMUFDNHVNQ2ZoRGFSX2U1cksyLWthMlBFNEZmMWEwbW1HUkVZX2hWc2ppczRuVkdwYTgtSFZvcUdjWGtVaE12WW9vdVA4SnV4cUFzMTJxRllCSllkRm9vaTB5c1lZb0l2anVaUTBtZG00?oc=5" target="_blank">IGA Str…
Should FDA’s IgA Nephropathy BLA Acceptance for Povetacicept Reshape Vertex Pharmaceuticals’ (VRTX) Investment Narrative? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxQR0pBMXFiQldvaUJGX21VbTZmZWF1bDV3UzVsMHhNTUpFYnc1WWpyaFhVMmZwcWZNSUlvVmJOYVIxUXdZUGpQRDd3YnFpYXFMS2R6Mk5scWh2V29RNG9pa0UxWEJCMmhtai1SZUM5ZnZ5dVUxXzRhdlduZGplTUNXSFM5d3RHcXFHZGNZU1…
IGA — Frequently Asked Questions
What is the current share price of IGA?
As of 2026-09-07 16:24 PDT, IGA trades at $10.54 on NASDAQ/NYSE. Its 52-week range is $8.66 to $10.67.
Is IGA a good stock to buy?
This page provides a data-driven analysis of IGA, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.